Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Liang Ho

Showing results (21-30 of 157) with videos related to

Pageof 16
Sort By:
Molecular and Clinical Oncology|January 26, 2016
A phase I multicenter study of antroquinonol in patients with metastatic non-small-cell lung cancer who have received at least two prior systemic treatment regimens, including one platinum-based chemotherapy regimenYu-Chin Lee, Ching-Liang Ho, Woei-Yau Kao, et al.
Haematologica|December 14, 2004
Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasiaBrijesh Arora, Ching-Liang Ho, James D Hoyer, et al.
Investigational New Drugs|March 13, 2021
Phase I first-in-human study of HLX07, a novel and improved recombinant anti-EGFR humanized monoclonal antibody, in patients with advanced solid cancersMing-Mo Hou, Ching-Liang Ho, Hsuan-Yu Lin, et al.
Acta Haematologica|November 29, 2008
Clinical correlates of serum pro-major basic protein in a spectrum of eosinophilic disorders and myelofibrosisChing-Liang Ho, Hirohito Kito, Diane L Squillace, et al.
Plos One|January 30, 2020
A network meta-analysis of maintenance therapy in chronic lymphocytic leukemiaCho-Hao Lee, Po-Huang Chen, Chin Lin, et al.
Journal of Clinical Medicine|May 1, 2019
Alternative-Dose versus Standard-Dose Trivalent Influenza Vaccines for Immunocompromised Patients: A Meta-Analysis of Randomised Control TrialsJiun-Ji Lai, Chin Lin, Ching-Liang Ho, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|June 8, 2002
Epstein-Barr virus and lymphoid hematological disordersAn-Tie Hsieh, Ching-Liang Ho, Yeu-Chin Chen, et al.
Oncology Letters|July 12, 2014
Clinicopathological analysis and prognostic factors of 11 patients with primary non-Hodgkin lymphoma of the small intestine in a single instituteJia-Hong Chen, Ching-Liang Ho, Yeu-Chin Chen, et al.
American Journal of Otolaryngology|July 9, 2021
Oral tegafur-uracil as a metronomic therapy in stage IVa and IVb cancer of the oral cavityWen-Yen Huang, Ching-Liang Ho, Tsu-Yi Chao, et al.
Head & Neck|August 23, 2019
Evaluation of oral tegafur-uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non-distant metastatic TNM stage IV nasopharyngeal carcinomaJia-Hong Chen, Wen-Yen Huang, Ching-Liang Ho, et al.
Pageof 16

Showing results (21-30 of 157) with videos related to

Sort By:
Pageof 16
Molecular and Clinical Oncology|January 26, 2016
A phase I multicenter study of antroquinonol in patients with metastatic non-small-cell lung cancer who have received at least two prior systemic treatment regimens, including one platinum-based chemotherapy regimenYu-Chin Lee, Ching-Liang Ho, Woei-Yau Kao, et al.
Haematologica|December 14, 2004
Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasiaBrijesh Arora, Ching-Liang Ho, James D Hoyer, et al.
Investigational New Drugs|March 13, 2021
Phase I first-in-human study of HLX07, a novel and improved recombinant anti-EGFR humanized monoclonal antibody, in patients with advanced solid cancersMing-Mo Hou, Ching-Liang Ho, Hsuan-Yu Lin, et al.
Acta Haematologica|November 29, 2008
Clinical correlates of serum pro-major basic protein in a spectrum of eosinophilic disorders and myelofibrosisChing-Liang Ho, Hirohito Kito, Diane L Squillace, et al.
Plos One|January 30, 2020
A network meta-analysis of maintenance therapy in chronic lymphocytic leukemiaCho-Hao Lee, Po-Huang Chen, Chin Lin, et al.
Journal of Clinical Medicine|May 1, 2019
Alternative-Dose versus Standard-Dose Trivalent Influenza Vaccines for Immunocompromised Patients: A Meta-Analysis of Randomised Control TrialsJiun-Ji Lai, Chin Lin, Ching-Liang Ho, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|June 8, 2002
Epstein-Barr virus and lymphoid hematological disordersAn-Tie Hsieh, Ching-Liang Ho, Yeu-Chin Chen, et al.
Oncology Letters|July 12, 2014
Clinicopathological analysis and prognostic factors of 11 patients with primary non-Hodgkin lymphoma of the small intestine in a single instituteJia-Hong Chen, Ching-Liang Ho, Yeu-Chin Chen, et al.
American Journal of Otolaryngology|July 9, 2021
Oral tegafur-uracil as a metronomic therapy in stage IVa and IVb cancer of the oral cavityWen-Yen Huang, Ching-Liang Ho, Tsu-Yi Chao, et al.
Head & Neck|August 23, 2019
Evaluation of oral tegafur-uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non-distant metastatic TNM stage IV nasopharyngeal carcinomaJia-Hong Chen, Wen-Yen Huang, Ching-Liang Ho, et al.
Pageof 16